JOLT HEALTH INC. ANNOUNCES FINANCING
November 22, 2023 16:59 ET
|
Jolt Health Inc.
VANCOUVER, BC, CANADA, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (“JOLT” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) announced it is undertaking a non-brokered private placement of up to...
JOLT HEALTH INC. ANNOUNCES CLOSING
July 19, 2023 12:41 ET
|
Jolt Health Inc.
VANCOUVER, BC, CANADA, July 19, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (“JOLT” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) announced, as per CSE policy, that it has closed its previously...
JOLT HEALTH INC. ANNOUNCES CLOSING
July 10, 2023 17:29 ET
|
Jolt Health Inc.
VANCOUVER, BC, CANADA, July 10, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (“JOLT” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) announced as per CSE policy, that is intends to close its previously...
JOLT HEALTH INC. ANNOUNCES FINANCING
June 15, 2023 18:39 ET
|
Jolt Health Inc.
VANCOUVER, BC, CANADA, June 15, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (“JOLT” and or “the Company”) (CSE:JOLT) (FSE: G1Q0) announced it is undertaking a non-brokered private placement of up to...
JOLT HEALTH INC. ANNOUNCES NEW CEO AND DIRECTOR TO LEAD BIOTECHNOLOGY, HEALTHCARE AND AI INITIATIVES
June 02, 2023 10:00 ET
|
Jolt Health Inc.
VANCOUVER, BC, CANADA, June 02, 2023 (GLOBE NEWSWIRE) -- Jolt Health Inc. (“JOLT” and or “The Company”)(CSE: JOLT) (FSE: G1Q0) (previously Love Pharma), the Company, is thrilled to announce that Mr....